Business Wire Feed
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence
Agreement will leverage Evinova’s innovative AI-native platform to improve trial design, accelerate timelines, and enhance cost efficiencyBAAR, Switzerland--(BUSINESS WIRE)--Evinova today announced that Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s more...
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in reducing disability progression in PPMS – – Fenebrutinib more...
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
OMNY-AF pilot study reports 90% 12-month freedom from AFib with zero procedure-related adverse eventsi Additional data presented further reinforces the favorable and consistent safety and efficiency profile of the VARIPULSE platformii,iii,iv,vIRVINE, Calif.--(BUSINESS WIRE)--Johnson & Johnson more...
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
Decision removes last patent hurdle as Geneoscopy advances ColoSense®, its RNA-based noninvasive colorectal cancer screening testST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today more...
ŌURA Named Official Wearable of Team USA and LA28 Olympic and Paralympic Games
SAN FRANCISCO--(BUSINESS WIRE)--ŌURA, maker of the world’s leading smart ring, Oura Ring, today announced a strategic partnership as the Official Wearable of Team USA and the LA28 Olympic & Paralympic Games. As Team USA and more...
Dr. Joseph Chang Launches Update to Bestselling Book “The Aging Myth” With 15 More Years of Breakthrough Research on Cellular Wellness
The updated edition of the New York Times bestseller from the chair of the Nu Skin Scientific Advisory Board reveals latest science behind measurable biology and evidence-based longevityPROVO, Utah--(BUSINESS WIRE)--Nu Skin Enterprises Inc. (NYSE: NUS) more...
Trividia Health, Inc. Initiates Labeling Correction for all TRUE METRIX® Blood Glucose Monitoring Systems
FT. LAUDERDALE, Fla.--(BUSINESS WIRE)--Trividia Health, Inc., announced today that it is initiating a labeling correction which requires a modification of the Owner’s Booklets/System Instructions for Use for all TRUE METRIX, TRUE METRIX AIR, TRUE METRIX more...
OnMed Named 2026 Impact Product of the Year by Impact One Awards
Award recognizes OnMed’s critical role in transforming access to healthcareNEW YORK--(BUSINESS WIRE)--OnMed, the leader in tech-enabled hybrid healthcare, has been named Impact Product of the Year by the Impact One Awards — one of the more...
TRUBAR Acquired by ETi Gıda for $173 Million, Ushering in Next Phase of Global Growth
Founder and leadership team to remain in place as brand accelerates North American scale and international expansionMIAMI--(BUSINESS WIRE)--TRUBAR, the fast-growing protein bar brand known for its dessert-inspired flavors and clean ingredients, today announced the completion more...
Colgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, and SVP, Global Growth and Innovation, Hill’s Pet Nutrition, Caroline Chulick, will present on Friday, February 20, 2026 at 8:00 am ET at the Consumer more...
Afya Limited Announces Medical Seats Increase in Afya Abaetetuba
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and provider of medical practice solutions in Brazil, today announced that the Secretary of Regulation and Supervision more...
Niagen Bioscience to Report Fourth Quarter and Full Year 2025 Financial Results on Wednesday, March 4, 2026
LOS ANGELES--(BUSINESS WIRE)--$NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on Wednesday, more...
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
– Limitations of Use Removed for Rare and Aggressive Form of non-Hodgkin Lymphoma Based on Manageable Safety Profile with No New Safety Signals Identified –SANTA MONICA, Calif.--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), today announced more...
EMD Serono Advances Patient Access to IVF Medicines in the U.S., Aligned with National Health Priorities
EMD Serono’s complete fertility medication portfolio, including Gonal‑f®, the most‑prescribed follicle‑stimulating hormone in the U.S., is now accessible via TrumpRx.gov and FertilityInstantSavings.com New patient access pathways reinforce EMD Serono’s mission to support people facing infertility more...
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need
Submission is to expand HYMPAVZI indication to the treatment of hemophilia A or B patients 6 years and older with inhibitors, and pediatric patients (ages 6 to 11) without inhibitors If approved, HYMPAVZI would become more...
A Legacy of Brighter Smiles: Celebrating 24 Years of the Give Kids A Smile Program
The American Dental Association Foundation’s Give Kids A Smile Program Celebrates Milestone of Over 10 Million Children Reached with Essential Dental Services, in Partnership with Longtime Sponsors Henry Schein and Colgate-PalmoliveHOUSTON--(BUSINESS WIRE)--The American Dental Association more...
Natera Launches EDEN Study on Early Risk Assessment for Preeclampsia and Adverse Pregnancy Outcomes
Large prospective study to evaluate a non-invasive prenatal screening testAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the launch of EDEN, a large, multi-center prospective study more...
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
Brief Summary: GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medications At launch, GoodRx is the integrated pricing source on TrumpRx for Pfizer, including over 30 of Pfizer’s essential more...
Applied Medical Prevails in Antitrust Jury Trial Against Medtronic
Jury Awards $382 Million in DamagesRANCHO SANTA MARGARITA, Calif.--(BUSINESS WIRE)--Applied Medical announced today a significant legal victory that should help open the healthcare market to innovation and lower costs. A U.S. District Court jury unanimously more...
Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans
Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and more Affirms Pfizer’s commitment to reduce drug costs for millions of Americans through historic agreement with Trump administration NEW more...
Pulse Biosciences Presents Late-Breaking Data from nPulse™ Cardiac Catheter System First-In-Human Feasibility Study at the AF Symposium
Procedural success was achieved in 100% of evaluable patients at 6 months and 96% in 12 monthsHAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ more...
Cizzle Brands Corporation Announces CWENCH Hydration as Official Sports Drink of New York State Amateur Hockey Association; Provides Operational Update
The agreement continues Cizzle's strategic integration of CWENCH Hydration into the ecosystem of grassroots hockey players, coaches and communities, building visibility in the US.TORONTO--(BUSINESS WIRE)--Cizzle Brands Corporation (Cboe Canada: CZZL) (OTCQB: CZZLF) (Frankfurt: 8YF) (the more...
Weave to Announce Fourth Quarter and Full Year 2025 Financial Results on February 19, 2026
LEHI, Utah--(BUSINESS WIRE)--Weave (NYSE: WEAV), a leading all-in-one customer experience and payments software platform for small and medium-sized healthcare businesses, today announced it will release its financial results for the fourth quarter and full year more...
Aptar Reports Fourth Quarter and Annual 2025 Results
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery and consumer product dispensing, dosing and protection technologies, today reported the following fourth quarter results for the period ended December 31, 2025, as more...
Aro Biotherapeutics Reports Preliminary Efficacy for ABX1100, a Muscle-targeted GYS1 siRNA, in Patients with Late-Onset Pompe Disease (LOPD)
Oral presentation at 22nd Annual WORLDSymposium highlights sustained knockdown of GYS1 mRNA, favorable safety and tolerability, predictable pharmacokinetics, and biomarker reductions consistent with clinical response Phase 1b data support GYS1 inhibition as a potential therapeutic more...